Albinism: Modern Molecular Diagnosis

Total Page:16

File Type:pdf, Size:1020Kb

Albinism: Modern Molecular Diagnosis British Journal of Ophthalmology 1998;82:189–195 189 Br J Ophthalmol: first published as 10.1136/bjo.82.2.189 on 1 February 1998. Downloaded from PERSPECTIVE Albinism: modern molecular diagnosis Susan M Carden, Raymond E Boissy, Pamela J Schoettker, William V Good Albinism is no longer a clinical diagnosis. The past cytes and into which melanin is confined. In the skin, the classification of albinism was predicated on phenotypic melanosome is later transferred from the melanocyte to the expression, but now molecular biology has defined the surrounding keratinocytes. The melanosome precursor condition more accurately. With recent advances in arises from the smooth endoplasmic reticulum. Tyrosinase molecular research, it is possible to diagnose many of the and other enzymes regulating melanin synthesis are various albinism conditions on the basis of genetic produced in the rough endoplasmic reticulum, matured in causation. This article seeks to review the current state of the Golgi apparatus, and translocated to the melanosome knowledge of albinism and associated disorders of hypo- where melanin biosynthesis occurs. pigmentation. Tyrosinase is a copper containing, monophenol, mono- The term albinism (L albus, white) encompasses geneti- oxygenase enzyme that has long been known to have a cally determined diseases that involve a disorder of the critical role in melanogenesis.5 It catalyses three reactions melanin system. Each condition of albinism is due to a in the melanin pathway. The rate limiting step is the genetic mutation on a diVerent chromosome. The cutane- hydroxylation of tyrosine into dihydroxyphenylalanine ous hypopigmentation in albinism ranges from complete (DOPA) by tyrosinase, but tyrosinase does not act alone. absence of melanin to a minimal reduction in skin and hair There is a melanogenic complex in the melanocyte, colour.1 On the other hand, the ocular phenotypic charac- functioning as an integrated unit, which consists of tyrosi- teristics of most types of albinism are rather constant and nase, tyrosinase related protein 1 (TRP-1), TRP-2, include reduced visual acuity, nystagmus, pale irides that lysosome associated membrane protein 1, and melanocyte transilluminate, hypopigmented fundi, hypoplastic foveae, stimulating hormone receptors.6 TRP-1 and TRP-2 have and lack of stereopsis. Pleiotropy is exhibited by all types of multiple functions, one of which is to stabilise tyrosinase albinism; single gene mutations have eVects on diVerent activity.57 organ systems. The most obvious systems involved are the A putative tyrosinase transporter is situated in the limit- integument and the eyes, but the nervous, haematological, ing membrane of the pre-melanosome. The P polypeptide respiratory, and gastrointestinal systems may occasionally is the product of the pink eye dilution locus (named from be aVected. the mouse) and the counterpart on human chromosome http://bjo.bmj.com/ Three major mechanisms exist by which mutations exert 15 (15q11.2-13). It has been proposed,8 and refuted,9 that their eVect on the pigmentation process. Firstly, abnormal the P protein transports tyrosine into the melanosome. pigmentation may occur early in the pathway of diVeren- tiation of melanocytes. Melanoblasts from the neural crest Classification might be aVected along with cells from the same lineage, See Table 1. such as occurs in Waardenberg and Waardenberg– In the past, the classification of albinism has had a Hirschsprung syndrome where the melanocyte fails to dichotomous foundation, based on whether the phenotype on September 26, 2021 by guest. Protected copyright. populate certain areas during embryogenesis. Secondly, a was oculocutaneous or simply ocular. Recently, investiga- mutation can aVect the melanin biochemical pathway tions have become more sophisticated and some cases have causing a more specific abnormality. Oculocutaneous albi- been reclassified. For example, one third of cases initially nism type 1 (OCA 1) is an example of such a condition. labelled as OCA 2 can be reclassified as OCA 1B on the Thirdly, the biogenesis of intracellular organelles of diVer- basis of molecular genetic studies.10 OCA 1 and OCA 2 ent cells may need a common set of genes and one gene were originally separated on the basis of the hair bulb test, mutation could aVect seemingly unrelated cell types, which is now considered unreliable. We can now review the including the melanocyte. Chediak–Higashi and molecular classification of various albino conditions. Hermansky–Pudlak syndromes are disease examples. Oculocutaneous albinism Melanin physiology “Oculocutaneous albinism” refers to a heterogeneous Pigmented cells of the eye have one of two origins. The group of autosomal recessive disorders in which melanin is retinal pigment epithelium, the posterior and anterior iris reduced or absent. Pale skin and an increased risk of skin epithelium, and the outer pigmented and inner non- cancer, together with the previously mentioned ocular pigmented (so called) ciliary epithelium are all derived phenotype, are present. from the neuroectoderm of the primitive forebrain. On the other hand, melanocytes in the iris stroma, ciliary stroma, OCA 1 and choroid are derived from the neural crest. Melano- OCA 1 results from mutations in the tyrosinase gene blasts from the neural crest migrate to the skin, brain, inner aVecting its synthesis and/or catalytic activity.11 Three steps ear, and uveal tract to develop into melanocytes.2–4 in melanin biosynthesis are catalysed by tyrosinase.12 OCA The biochemical pathway converting tyrosine to mela- 1 is further divided into OCA 1A and OCA 1B. DiVerent nin is shown in Figure 1. The pigment granule (melano- types of mutations of the gene for tyrosinase explain the some) is an intracellular organelle produced by melano- two types of OCA 1. The gene position is on chromosome 190 Carden, Boissy, Schoettker, Good Br J Ophthalmol: first published as 10.1136/bjo.82.2.189 on 1 February 1998. Downloaded from Tyrosine tyrosinase (tyrosine hydroxylase activity) dihydroxyphenylalanine (DOPA) tyrosinase (dopa oxidase activity) DOPAquinone glutathione or cysteine spontaneous cysteinyl DOPA LeucoDOPAchrome spontaneous intermediates DOPAchrome DOPAchrome tautomerase (TRP-2) 5,6-dihydroxyindole 5,6-dihydroxyindole carboxylic acid tyrosinase or (peroxidase) DHICA oxidase Indole-5,6-quinone indole-5,6-quinone carboxylic acid pheomelanins (yellow and red polymers) eumelanins (black and brown polymers) Figure 1 Biosynthesis of melanin. http://bjo.bmj.com/ 11 (11q14-21).13 OCA 1A is the most severe form of OCA. Fifty five mutations of the tyrosinase (TYR) gene have Tyrosinase activity is completely absent and there is no been found to date.14 melanin in the skin or eyes (fig 2). Visual acuity is The phenotype of OCA 1B is indistinguishable from decreased to 20/400.11 Nonsense, frameshift, and missense OCA 1A at birth. Tyrosinase activity modulates pigmenta- mutations account for OCA 1A. OCA 1B has a greatly tion and causes a darker skinned phenotype during diminished, but not absent, level of tyrosinase. OCA 1B childhood.11 OCA 1B was originally described in the individuals may exhibit an increase in skin, hair, and eye Amish people,15 16 who are highly inbred. The condition pigment with age and do tan with sun exposure (Fig 2). was formerly referred to as “yellow mutant.” on September 26, 2021 by guest. Protected copyright. Table 1 Conditions of albinism COMPOUND HETEROZYGOTES OCA 1A/1B compound heterozygotes share phenotypic Type of albinism Gene position attributes of OCA 1A and 1B. OCA 1 phenotypes can OCA 1 11q14-21 result from homozygosity or compound heterozygosity of OCA 1A the alleles. In white people there is no one mutant TYR OCA 1B allele that is responsible for most of the mutations. Thus, if OCA 2 15q11-13 OCA 3 9p23 the parents are not related then the patient will probably be 14 OA 1 Xp22.3-22.2 a compound heterozygote. ?OA 2 An OCA 1A patient must have two type OCA 1A alleles; Chediak–Higashi 1q42-44 Hermansky–Pudlak 10q23.1-23.3 an OCA 1B can have two type OCA 1B alleles or one type 1A and one type 1B allele. This explains why the Contiguous gene syndromes phenotype of OCA 1B has such a broad spectrum. Even a Prader–Willi (OCA 2) 15q11-13 Angelman (OCA 2) 15q11-13 small amount of tyrosinase activity will alter the pheno- Kallmann syndrome (OA 1) Xp22.3-22.4 typic expression.14 Late onset sensorineural deafness Xp22 (OA 1) Xp22 X linked ichthyosis and Kallmann syndrome (OA 1) Xp22 OCA 2 Microphthalmia and linear skin defects (OA 1) Xp22 OCA 2 has a prevalence of 1:15 000. Patients with OCA 2 Aicardi Xp22 were formerly referred to as “tyrosinase positive” oculocu- Goltz Xp22 Waardenburg 1 2q35-q37.3 taneous albinos because the mutation causing OCA 2 does Waardenburg 2 3p12 not aVect the tyrosinase gene, instead aVecting the P Waardenburg 3 2q35-q37.3 81718 Warrdenburg–Hirschsprung 13q22 polypeptide. The disease is also autosomal recessive, but coded on a diVerent chromosome from OCA 1—that Albinism: modern molecular diagnosis 191 mutation results in the disregulation of tyrosinase activity Br J Ophthalmol: first published as 10.1136/bjo.82.2.189 on 1 February 1998. Downloaded from and the synthesis of brown rather than black melanin.21 In mice, TRP-1 catalytically functions as a dihydroxyindole carboxylic acid (DHICA) oxidase24 25 and may aid in stabi- lisation of tyrosinase and other melanosomal enzymatic processes.7 There may be an interaction with TRP-1 and tyrosinase to aVect tyrosinase hydroxylase activity. TRP-1 may also upregulate the availability of L-DOPA during the onset of melanogenesis.26 27 Ocular albinism OCULAR ALBINISM 1 X linked recessive ocular albinism (Nettleship–Falls type) is categorised as ocular albinism type 1 (OA 1). It has a prevalence of 1:50 000 in the United States.11 The OA 1 locus is 5p22-3.28–32 Charles et al 32 looked at 72 cases of OA 1 and found nystagmus (in all cases except one), reduced visual acuity (to 6/36 in most cases), refractive errors Figure 2 Photograph of child with oculocutaneous albinism 1A.
Recommended publications
  • Melanocytes and Their Diseases
    Downloaded from http://perspectivesinmedicine.cshlp.org/ on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Melanocytes and Their Diseases Yuji Yamaguchi1 and Vincent J. Hearing2 1Medical, AbbVie GK, Mita, Tokyo 108-6302, Japan 2Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Correspondence: [email protected] Human melanocytes are distributed not only in the epidermis and in hair follicles but also in mucosa, cochlea (ear), iris (eye), and mesencephalon (brain) among other tissues. Melano- cytes, which are derived from the neural crest, are unique in that they produce eu-/pheo- melanin pigments in unique membrane-bound organelles termed melanosomes, which can be divided into four stages depending on their degree of maturation. Pigmentation production is determined by three distinct elements: enzymes involved in melanin synthesis, proteins required for melanosome structure, and proteins required for their trafficking and distribution. Many genes are involved in regulating pigmentation at various levels, and mutations in many of them cause pigmentary disorders, which can be classified into three types: hyperpigmen- tation (including melasma), hypopigmentation (including oculocutaneous albinism [OCA]), and mixed hyper-/hypopigmentation (including dyschromatosis symmetrica hereditaria). We briefly review vitiligo as a representative of an acquired hypopigmentation disorder. igments that determine human skin colors somes can be divided into four stages depend- Pinclude melanin, hemoglobin (red), hemo- ing on their degree of maturation. Early mela- siderin (brown), carotene (yellow), and bilin nosomes, especially stage I melanosomes, are (yellow). Among those, melanins play key roles similar to lysosomes whereas late melanosomes in determining human skin (and hair) pigmen- contain a structured matrix and highly dense tation.
    [Show full text]
  • Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D
    Update on Challenging Disorders of Pigmentation in Skin of Color Heather Woolery-Lloyd, M.D. Director of Ethnic Skin Care Voluntary Assistant Professor Miller/University of Miami School of Medicine Department of Dermatology and Cutaneous Surgery What Determines Skin Color? What Determines Skin Color? No significant difference in the number of melanocytes between the races 2000 epidermal melanocytes/mm2 on head and forearm 1000 epidermal melanocytes/mm2 on the rest of the body differences present at birth Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB (1999) Biology of melanocytes. In I. M. Freedberg, A.Z. Eisen, K. Wolff,K.F. Austen, L.A. Goldsmith, S. I. Katz, T. B. Fitzpatrick (Eds.), Dermatology in General Medicine 5th ed., pp192-220, New York, NY: McGraw Hill Melanosomes in Black and White Skin Black White Szabo G, Gerald AB, Pathak MA, Fitzpatrick TB. Nature1969;222:1081-1082 Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB (1999) Biology of melanocytes. In I. M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S. I. Katz, T. B. Fitzpatrick (Eds.), Dermatology in General Medicine 5th ed., pp192- 220, New York, NY: McGraw Hill Role of Melanin-Advantages Melanin absorbs and scatters energy from UV and visible light to protect epidermal cells from UV damage Disadvantages Inflammation or injury to the skin is almost immediately accompanied by alteration in pigmentation Hyperpigmentation Hypopigmentation Dyschromias Post-Inflammatory hyperpigmentation Acne Melasma Lichen Planus Pigmentosus Progressive Macular Hypomelanosis
    [Show full text]
  • Genetic Testing for Non-Cancerous Inheritable Diseases
    Genetic Testing for Non-Cancerous Inheritable Diseases Policy Number: Original Effective Date: MM.02.009 03/01/2010 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 12/30/2016 Section: Medicine Place(s) of Service: Outpatient I. Description A genetic test is the analysis of human DNA, RNA, chromosomes, proteins, or certain metabolites in order to detect alterations related to an inheritable disorder. This can be accomplished by directly examining the DNA or RNA that makes up a gene (direct testing), looking at markers co-inherited with a disease-causing gene (linkage testing), assaying certain metabolites (biochemical testing), or examining the chromosomes (cytogenetic testing). Genetic tests are conducted for a number of purposes, including predicting disease risk, newborn screening, determining clinical management, identifying carriers, and establishing prenatal or clinical diagnoses or prognoses in individuals, families, or populations. Expanded Carrier Screening The American College of Medical Genetics (ACMG ) defines expanded panels as those that use next- generation sequencing to screen for mutations in many genes, as opposed to gene-by-gene screening (e.g., ethnic-specific screening or panethnic testing for cystic fibrosis). An ACMG position statement states that although commercial laboratories offer expanded carrier screening panels, there has been no professional guidance as to which disease genes and mutations to include. This policy does not address oncology-related genetic testing or pre-implantation genetic diagnosis (PGD). II. Criteria/Guidelines Note: For familial assessments, unless otherwise specified, family will be considered: first-, second- and third- degree relatives on the same side of the family. The maternal and paternal sides should be considered independently.
    [Show full text]
  • Natural Skin‑Whitening Compounds for the Treatment of Melanogenesis (Review)
    EXPERIMENTAL AND THERAPEUTIC MEDICINE 20: 173-185, 2020 Natural skin‑whitening compounds for the treatment of melanogenesis (Review) WENHUI QIAN1,2, WENYA LIU1, DONG ZHU2, YANLI CAO1, ANFU TANG1, GUANGMING GONG1 and HUA SU1 1Department of Pharmaceutics, Jinling Hospital, Nanjing University School of Medicine; 2School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210002, P.R. China Received June 14, 2019; Accepted March 17, 2020 DOI: 10.3892/etm.2020.8687 Abstract. Melanogenesis is the process for the production of skin-whitening agents, boosted by markets in Asian countries, melanin, which is the primary cause of human skin pigmenta- especially those in China, India and Japan, is increasing tion. Skin-whitening agents are commercially available for annually (1). Skin color is influenced by a number of intrinsic those who wish to have a lighter skin complexions. To date, factors, including skin types and genetic background, and although numerous natural compounds have been proposed extrinsic factors, including the degree of sunlight exposure to alleviate hyperpigmentation, insufficient attention has and environmental pollution (2-4). Skin color is determined by been focused on potential natural skin-whitening agents and the quantity of melanosomes and their extent of dispersion in their mechanism of action from the perspective of compound the skin (5). Under physiological conditions, pigmentation can classification. In the present article, the synthetic process of protect the skin against harmful UV injury. However, exces- melanogenesis and associated core signaling pathways are sive generation of melanin can result in extensive aesthetic summarized. An overview of the list of natural skin-lightening problems, including melasma, pigmentation of ephelides and agents, along with their compound classifications, is also post‑inflammatory hyperpigmentation (1,6).
    [Show full text]
  • EXTENDED CARRIER SCREENING Peace of Mind for Planned Pregnancies
    Focusing on Personalised Medicine EXTENDED CARRIER SCREENING Peace of Mind for Planned Pregnancies Extended carrier screening is an important tool for prospective parents to help them determine their risk of having a child affected with a heritable disease. In many cases, parents aren’t aware they are carriers and have no family history due to the rarity of some diseases in the general population. What is covered by the screening? Genomics For Life offers a comprehensive Extended Carrier Screening test, providing prospective parents with the information they require when planning their pregnancy. Extended Carrier Screening has been shown to detect carriers who would not have been considered candidates for traditional risk- based screening. With a simple mouth swab collection, we are able to test for over 419 genes associated with inherited diseases, including Fragile X Syndrome, Cystic Fibrosis and Spinal Muscular Atrophy. The assay has been developed in conjunction with clinical molecular geneticists, and includes genes listed in the NIH Genetic Test Registry. For a list of genes and disorders covered, please see the reverse of this brochure. If your gene of interest is not covered on our Extended Carrier Screening panel, please contact our friendly team to assist you in finding a gene test panel that suits your needs. Why have Extended Carrier Screening? Extended Carrier Screening prior to pregnancy enables couples to learn about their reproductive risk and consider a complete range of reproductive options, including whether or not to become pregnant, whether to use advanced reproductive technologies, such as preimplantation genetic diagnosis, or to use donor gametes.
    [Show full text]
  • Clinicopathological Correlation of Acquired Hyperpigmentary Disorders
    Symposium Clinicopathological correlation of acquired Dermatopathology hyperpigmentary disorders Anisha B. Patel, Raj Kubba1, Asha Kubba1 Department of Dermatology, ABSTRACT Oregon Health Sciences University, Portland, Oregon, Acquired pigmentary disorders are group of heterogenous entities that share single, most USA, 1Delhi Dermatology Group, Delhi Dermpath significant, clinical feature, that is, dyspigmentation. Asians and Indians, in particular, are mostly Laboratory, New Delhi, India affected. Although the classic morphologies and common treatment options of these conditions have been reviewed in the global dermatology literature, the value of histpathological evaluation Address for correspondence: has not been thoroughly explored. The importance of accurate diagnosis is emphasized here as Dr. Asha Kubba, the underlying diseases have varying etiologies that need to be addressed in order to effectively 10, Aradhana Enclave, treat the dyspigmentation. In this review, we describe and discuss the utility of histology in the R.K. Puram, Sector‑13, diagnostic work of hyperpigmentary disorders, and how, in many cases, it can lead to targeted New Delhi ‑ 110 066, India. E‑mail: and more effective therapy. We focus on the most common acquired pigmentary disorders [email protected] seen in Indian patients as well as a few uncommon diseases with distinctive histological traits. Facial melanoses, including mimickers of melasma, are thoroughly explored. These diseases include lichen planus pigmentosus, discoid lupus erythematosus, drug‑induced melanoses, hyperpigmentation due to exogenous substances, acanthosis nigricans, and macular amyloidosis. Key words: Facial melanoses, histology of hyperpigmentary disorders and melasma, pigmentary disorders INTRODUCTION focus on the most common acquired hyperpigmentary disorders seen in Indian patients as well as a few Acquired pigmentary disorders are found all over the uncommon diseases with distinctive histological traits.
    [Show full text]
  • Dermatologic Manifestations of Hermansky-Pudlak Syndrome in Patients with and Without a 16–Base Pair Duplication in the HPS1 Gene
    STUDY Dermatologic Manifestations of Hermansky-Pudlak Syndrome in Patients With and Without a 16–Base Pair Duplication in the HPS1 Gene Jorge Toro, MD; Maria Turner, MD; William A. Gahl, MD, PhD Background: Hermansky-Pudlak syndrome (HPS) con- without the duplication were non–Puerto Rican except sists of oculocutaneous albinism, a platelet storage pool de- 4 from central Puerto Rico. ficiency, and lysosomal accumulation of ceroid lipofuscin. Patients with HPS from northwest Puerto Rico are homozy- Results: Both patients homozygous for the 16-bp du- gous for a 16–base pair (bp) duplication in exon 15 of HPS1, plication and patients without the duplication dis- a gene on chromosome 10q23 known to cause the disorder. played skin color ranging from white to light brown. Pa- tients with the duplication, as well as those lacking the Objective: To determine the dermatologic findings of duplication, had hair color ranging from white to brown patients with HPS. and eye color ranging from blue to brown. New findings in both groups of patients with HPS were melanocytic Design: Survey of inpatients with HPS by physical ex- nevi with dysplastic features, acanthosis nigricans–like amination. lesions in the axilla and neck, and trichomegaly. Eighty percent of patients with the duplication exhibited fea- Setting: National Institutes of Health Clinical Center, tures of solar damage, including multiple freckles, stel- Bethesda, Md (a tertiary referral hospital). late lentigines, actinic keratoses, and, occasionally, basal cell or squamous cell carcinomas. Only 8% of patients Patients: Sixty-five patients aged 3 to 54 years were di- lacking the 16-bp duplication displayed these findings.
    [Show full text]
  • Aberrant Colourations in Wild Snakes: Case Study in Neotropical Taxa and a Review of Terminology
    SALAMANDRA 57(1): 124–138 Claudio Borteiro et al. SALAMANDRA 15 February 2021 ISSN 0036–3375 German Journal of Herpetology Aberrant colourations in wild snakes: case study in Neotropical taxa and a review of terminology Claudio Borteiro1, Arthur Diesel Abegg2,3, Fabrício Hirouki Oda4, Darío Cardozo5, Francisco Kolenc1, Ignacio Etchandy6, Irasema Bisaiz6, Carlos Prigioni1 & Diego Baldo5 1) Sección Herpetología, Museo Nacional de Historia Natural, Miguelete 1825, Montevideo 11800, Uruguay 2) Instituto Butantan, Laboratório Especial de Coleções Zoológicas, Avenida Vital Brasil, 1500, Butantã, CEP 05503-900 São Paulo, SP, Brazil 3) Universidade de São Paulo, Instituto de Biociências, Departamento de Zoologia, Programa de Pós-Graduação em Zoologia, Travessa 14, Rua do Matão, 321, Cidade Universitária, 05508-090, São Paulo, SP, Brazil 4) Universidade Regional do Cariri, Departamento de Química Biológica, Programa de Pós-graduação em Bioprospecção Molecular, Rua Coronel Antônio Luiz 1161, Pimenta, Crato, Ceará 63105-000, CE, Brazil 5) Laboratorio de Genética Evolutiva, Instituto de Biología Subtropical (CONICET-UNaM), Facultad de Ciencias Exactas Químicas y Naturales, Universidad Nacional de Misiones, Felix de Azara 1552, CP 3300, Posadas, Misiones, Argentina 6) Alternatus Uruguay, Ruta 37, km 1.4, Piriápolis, Uruguay Corresponding author: Claudio Borteiro, e-mail: [email protected] Manuscript received: 2 April 2020 Accepted: 18 August 2020 by Arne Schulze Abstract. The criteria used by previous authors to define colour aberrancies of snakes, particularly albinism, are varied and terms have widely been used ambiguously. The aim of this work was to review genetically based aberrant colour morphs of wild Neotropical snakes and associated terminology. We compiled a total of 115 cases of conspicuous defective expressions of pigmentations in snakes, including melanin (black/brown colour), xanthins (yellow), and erythrins (red), which in- volved 47 species of Aniliidae, Boidae, Colubridae, Elapidae, Leptotyphlopidae, Typhlopidae, and Viperidae.
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • A Genome-Wide Association Study Reveals a Locus for Bilateral Iridal Hypopigmentation in Holstein Friesian Cattle Anne K
    Hollmann et al. BMC Genetics (2017) 18:30 DOI 10.1186/s12863-017-0496-4 RESEARCHARTICLE Open Access A genome-wide association study reveals a locus for bilateral iridal hypopigmentation in Holstein Friesian cattle Anne K. Hollmann1, Martina Bleyer2, Andrea Tipold3, Jasmin N. Neßler3, Wilhelm E. Wemheuer1, Ekkehard Schütz1 and Bertram Brenig1* Abstract Background: Eye pigmentation abnormalities in cattle are often related to albinism, Chediak-Higashi or Tietz like syndrome. However, mutations only affecting pigmentation of coat color and eye have also been described. Herein 18 Holstein Friesian cattle affected by bicolored and hypopigmented irises have been investigated. Results: Affected animals did not reveal any ophthalmological or neurological abnormalities besides the specific iris color differences. Coat color of affected cattle did not differ from controls. Histological examination revealed a reduction of melanin pigment in the iridal anterior border layer and stroma in cases as cause of iris hypopigmentation. To analyze the genetics of the iris pigmentation differences, a genome-wide association study was performed using Illumina BovineSNP50 BeadChip genotypes of the 18 cases and 172 randomly chosen control animals. A significant association on bovine chromosome 8 (BTA8) was identified at position 60,990,733 with a -log10(p) = 9.17. Analysis of genotypic and allelic dependences between cases of iridal hypopigmentation and an additional set of 316 randomly selected Holstein Friesian cattle controls showed that allele A at position 60,990,733 on BTA8 (P =4.0e–08, odds ratio = 6.3, 95% confidence interval 3.02–13.17) significantly increased the chance of iridal hypopigmentation. Conclusions: The clinical appearance of the iridal hypopigmentation differed from previously reported cases of pigmentation abnormalities in syndromes like Chediak-Higashi or Tietz and seems to be mainly of cosmetic character.
    [Show full text]
  • Colorado Birds | Summer 2021 | Vol
    PROFESSOR’S CORNER Learning to Discern Color Aberration in Birds By Christy Carello Professor of Biology at The Metropolitan State University of Denver Melanin, the pigment that results in the black coloration of the flight feathers in this American White Pelican, also results in stronger feathers. Photo by Peter Burke. 148 Colorado Birds | Summer 2021 | Vol. 55 No.3 Colorado Birds | Summer 2021 | Vol. 55 No.3 149 THE PROFESSOR’S CORNER IS A NEW COLORADO BIRDS FEATURE THAT WILL EXPLORE A WIDE RANGE OF ORNITHOLOGICAL TOPICS FROM HISTORY AND CLASSIFICATION TO PHYSIOLOGY, REPRODUCTION, MIGRATION BEHAVIOR AND BEYOND. AS THE TITLE SUGGESTS, ARTICLES WILL BE AUTHORED BY ORNI- THOLOGISTS, BIOLOGISTS AND OTHER ACADEMICS. Did I just see an albino bird? Probably not. Whenever humans, melanin results in our skin and hair color. we see an all white or partially white bird, “albino” In birds, tiny melanin granules are deposited in is often the first word that comes to mind. In feathers from the feather follicles, resulting in a fact, albinism is an extreme and somewhat rare range of colors from dark black to reddish-brown condition caused by a genetic mutation that or even a pale yellow appearance. Have you ever completely restricts melanin throughout a bird’s wondered why so many mostly white birds, such body. Many birders have learned to substitute the as the American White Pelican, Ring-billed Gull and word “leucistic” for “albino,” which is certainly a Swallow-tailed Kite, have black wing feathers? This step in the right direction, however, there are many is due to melanin.
    [Show full text]
  • Preconception Carrier Screening
    Focusing on Personalised Medicine PRECONCEPTION CARRIER SCREENING Preconception carrier screening is an important tool for prospective parents to help them determine their risk of having a child affected with a heritable disease. In many cases, parents aren’t aware they are carriers and have no family history due to the rarity of some diseases in the general population. What is covered by the screening? Our Inherited Disease Panel tests over 300 genes associated with more than 700 unique commonly inherited diseases, including common forms of inherited deafness, blindness, heart disease, Parkinson’s disease, immunodeficiency, and various ataxias, anaemias, and treatable metabolic syndromes. The assay has been developed in conjunction with clinical molecular geneticists, and includeds genes listed in the NIH Genetic Test Registry. For a full list of genes and disorders covered, please see the reverse of this brochure. Why have Preconception Carrier Screening? Carrier screening prior to pregnancy enables couples to learn about their reproductive risk and consider a complete range of reproductive options, including whether or not to become pregnant, whether to use advanced reproductive technologies, such as preimplantation genetic diagnosis, or use donor gametes. Screening also allows couples to consider prenatal diagnosis and pregnancy management options in the event of an affected fetus. Whilst individually each disease tested is rare, around 25% of people will carry at least one abnormal mutation. These disorders are usually autosomal recessive, which means that a child must inherit a defective gene from each parent to have the disease. For autosomal recessive conditions, if a person is a carrier of the disease, they have one defective copy of the gene and one normal copy and typically don’t have any symptoms of the disease.
    [Show full text]